TURIN/AMSTERDAM (Reuters) - The CEO of Exor NV, the largest shareholder in Dutch healthcare equipment maker Philips NV, on Thursday said he continues to believe the company's problems are solvable.

Health technology company Philips is investing more than $150 million in manufacturing and research and development in the U.S. and is expanding manufacturing facilities in Pennsylvania and Minnesota.

Medical device company Philips reached a settlement Monday to shell out $1.1 billion to cover hundreds of personal injury lawsuits linked to its respiration and sleep apnea machines. The manufacturer ...

Philips Respironics announced last Monday that it’s stopping sales of their breathing machines within the U.S. following a mid-2021 product recall. The decision, as reported by The New York Times, was ...

Phillips Edison & Company, Inc. (PECO) came out with quarterly funds from operations (FFO) of $0.66 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.62 per share a ...

Medical device maker Phillips formally entered into a consent decree that stops the company from selling sleep apnea machines in the United States over health concerns that include cancer. The decree ...

Hospitals are intimidating even for adults, but they’re particularly overwhelming for pediatric patients, millions of whom are hospitalized every year. Multinational company Philips is known in ...

This morning Royal Philips announced its plans to acquire med tech Capsule Technologies for a whopping $635 million from Francisco Partners. Capsule is best known for its suite of connected medical ...

TURIN/AMSTERDAM, Nov 30 (Reuters) - The CEO of Exor NV (EXOR.AS), opens new tab, the largest shareholder in Dutch healthcare equipment maker Philips NV (PHG.AS), opens new tab, on Thursday said he ...